Women's views of the climacteric at the time of low menopausal hormone use, Estonia 1998

Maturitas

Volumn 51, Issue 4, 2005, Pages 413-425

  Hovi, Sirpa Liisa ^a,b   Veerus, Piret ^b,c   Karro, Helle ^d   Topo, Päivi ^a   Hemminki, Elina ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^d UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE;

ADRENERGIC SYSTEM; ADULT; ARTICLE; ATTITUDE; AWARENESS; CLIMACTERIUM; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG USE; ESTONIA; ETHNIC GROUP; FATIGUE; FEMALE; GENERAL PRACTITIONER; HEALTH; HEALTH CARE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; MENOPAUSE; PHYSICIAN; POSTAL MAIL; POSTMENOPAUSE; QUESTIONNAIRE; RANDOMIZATION; SAMPLE; SAMPLING; SELF CONCEPT; SOCIAL CLASS; SYMPTOM;

CLIMACTERIC; ESTONIA; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; PHYSICIANS; POSTMENOPAUSE; QUESTIONNAIRES;

EID: 22544444922     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.11.001     Document Type: Article

References (38)

1. P.A. Kaufert, P. Gilbert, and T. Hassard Researching the symptoms of menopause: an exercise in methodology Maturitas 10 1988 117 131
2. M.S. Hunter Somatic experience of the menopause: a prospective study Psychosom Med 52 1990 357 367
3. E. Hemminki, P. Topo, M. Malin, and I. Kangas Physicians' views on hormone therapy around and after menopause Maturitas 16 1993 163 173
4. E. Hemminki, P. Topo, and I. Kangas Experiences and opinions of climacterium by Finnish women Eur J Obstet Gyn Reprod Biol 62 1995 81 87
5. A. Holte Prevalence of climacteric complaints in a representative sample of middle-aged women in Oslo, Norway J Psychosom Obst Gyn 12 1991 303 317
6. C.A. Morse, A. Smith, L. Dennerstein, A. Green, J. Hopper, and H. Burger The treatment-seeking women at menopause Maturitas 18 1994 161 173
7. A. Bardel, M.-A. Wallander, and K. Svärsudd Hormone replacement therapy and symptom reporting in menopausal women. A population-based study of 35-65-year-old women in mid-Sweden Maturitas 41 2002 7 15
8. E. Stadberg, L.A. Mattsson, and I. Milsom Factors associated with climacteric symptoms and the use of hormone replacement therapy Acta Obstet Gyn Scan 79 4 2000 286 292
9. W.H. Utian Direction, misdirection and misconception in menopause research and management. Br J Obstet Gynaec 103 1996 736 739
10. S. Hulley, C. Furberg, and E. Barrett-Connor HERS Research Group. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement (HERS II) study follow-up J Am Med Assoc 288 1 2002 58 66
11. J.E. Rossouw Writing group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial J Am Med Assoc 288 2002 321 333
12. P. Topo, E. Hemminki, and A. Uutela Women's choice and physicians' advice on use of menopausal and postmenopausal hormone therapy Int J Health Sci 4 3 1993 101 109
13. A. MacLaren, and N.F. Woods Midlife women making hormone therapy decisions Women Health Iss 11 3 2001 216 230
14. K.J. Lewin, H.K. Sinclair, and C.M. Bond Women's knowledge of attitudes towards hormone replacement therapy Fam Pract 20 2 2003 112 119
15. E. Hemminki, and P. Topo Prescribing of hormone therapy in menopause and postmenopause J Psychosom Obst Gyn 18 1997 145 157
16. S. Rozenberg, C. Fellemans, M. Kroll, and J. Vandromme The menopause in Europe Int J Fertil 45 2 2000 182 189
17. J.V. Jolleys, and F. Olesen A comparative study of prescribing of hormone replacement therapy in USA and Europe Maturitas 23 1996 47 53
18. S.-L. Hovi, T. Karttunen, H. Karro, and E. Hemminki Comparison of Estonian and Finnish physicians' opinions of menopause and hormone therapy Maturitas 49 2004 1070 1113
19. NOMESCO. Health statistics in the Nordic countries 2000. Nordic Medico Statistical Committee 64:2002.
20. J. Lomranz, D. Becker, N. Eyal, A. Pines, and R. Mester Attitudes towards hormone replacement therapy among middle-aged women and men Eur J Obstet Gyn R B 93 2000 100 203
21. A.J. Søgaard, A. Tollan, G.K.R. Berntsen, V. Fønnebø , and J.H. Magnus Hormone replacement therapy: knowledge, attitudes, self-reported use and sales figures in Nordic women Maturitas 35 2000 201 214
22. J. Akong, K.N. Hoon, and C. Dial Hormone replacement therapy. Knowledge, attitudes and practices of women attending a gynaecology outpatient clinic in Trinidad W Indian Med J 50 2 2001 155 158
23. L. Hvas Positive aspects of menopause: a qualitative study Maturitas 39 2001 11 17
24. P. Topo Climacteric hormone therapy in medical and lay texts in Finland from 1955 to 1992 Soc Sci Med 45 5 1997 751 760
25. E. Hemminki Hormone replacement therapy: discrepancies between evidence and recommendations Scand J Public Health 28 2000 81 83
26. V. Stearns, L. Ullmer, J.F. Lopez, Y. Smith, C. Isaacs, and D.F. Hayes Hot flushes Lancet 360 2002 1851 1861
27. L.W. Maartens, G.L. Leusink, J.A. Knotterus, and V.J. Pop Hormonal substitution during menopause: what are we treating? Maturitas 34 2000 113 118
28. C.T. Liverman D.G. Blazer Testosterone and aging. Clinical research directions 2004 The National Academics Press Washington, DC
29. E. Hemminki, T. Karttunen, S-L. Hovi, and H. Karro The drug industry and medical practice - the case of menopausal hormone therapy in Estonia Soc Sci Med 58 2004 89 97
30. E. Hemminki, and K. McPherson Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials Br Med J 315 7101 1997 149 153
31. V. Beral Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study Lancet 362 9382 2003 419 427
32. S.A. Shumaker, C. Legault, and S.R. Rapp WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative Memory Study: a randomized controlled trial JAMA 289 2003 2651 2662
33. S.A. Shumaker, C. Legault, and L. Kuller Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. Women's Health Initiative Memory Study JAMA 291 2004 2947 2958
34. S.R. Rapp, M.A. Espeland, and S.A. Shumaker WHIMS Investigators. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial JAMA 289 20 2003 2663 2672
35. J. Hays, J.K. Ockene, and R.L. Brunner Valanis, for the Women's Health Initiative Investigators. Effects of estrogen plus progestin on health-related quality of life N Engl J Med 348 2003 1839 1854
36. J.E. Manson, J. Hsia, K.C. Johnson, and M. Cushman Estrogen plus progestin and the risk of coronary heart disease N Engl J Med 349 2003 523 534
37. S. Wassertheil-Smoller, S.L. Hendrix, and M. Limacher WHI Investigators. Effect of estrogen plus progestin on stroke in postmenopausal women. The Women's Health Initiative: a randomized trial JAMA 289 2003 2673 2684
38. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004; 291:1701-1712.